These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12415597)

  • 61. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.
    Miller FW; Leitman SF; Cronin ME; Hicks JE; Leff RL; Wesley R; Fraser DD; Dalakas M; Plotz PH
    N Engl J Med; 1992 May; 326(21):1380-4. PubMed ID: 1472183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.
    Alexanderson H; Regardt M; Ottosson C; Alemo Munters L; Dastmalchi M; Dani L; Lundberg IE
    J Rheumatol; 2018 Apr; 45(4):538-546. PubMed ID: 29419464
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Seasonal occurrence of relapses in inflammatory myopathies: a preliminary study.
    Phillips BA; Zilko PJ; Garlepp MJ; Mastaglia FL
    J Neurol; 2002 Apr; 249(4):441-4. PubMed ID: 11967650
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Validity and test-retest reliability of a disability questionnaire for essential tremor.
    Louis ED; Barnes LF; Wendt KJ; Albert SM; Pullman SL; Yu Q; Schneier FR
    Mov Disord; 2000 May; 15(3):516-23. PubMed ID: 10830418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis.
    Clarke AE; Bloch DA; Medsger TA; Oddis CV
    Arthritis Rheum; 1995 Sep; 38(9):1218-24. PubMed ID: 7575715
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index.
    Rider LG; Lachenbruch PA; Monroe JB; Ravelli A; Cabalar I; Feldman BM; Villalba ML; Myones BL; Pachman LM; Rennebohm RM; Reed AM; Miller FW;
    Arthritis Rheum; 2009 Nov; 60(11):3425-35. PubMed ID: 19877055
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of a functional disability measurement tool to assess early arthritis: the Recent-Onset Arthritis Disability (ROAD) questionnaire.
    Salaffi F; Bazzichi L; Stancati A; Neri R; Cazzato M; Consensi A; Grassi W; Bombardieri S
    Clin Exp Rheumatol; 2005; 23(5):628-36. PubMed ID: 16173238
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis.
    Alemo Munters L; van Vollenhoven RF; Alexanderson H
    ISRN Rheumatol; 2011; 2011():463124. PubMed ID: 22389795
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Disease-specific quality indicators, outcome measures and guidelines in polymyositis and dermatomyositis.
    Alexanderson H; Lundberg IE
    Clin Exp Rheumatol; 2007; 25(6 Suppl 47):153-8. PubMed ID: 18021522
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.
    Huber AM; Dugan EM; Lachenbruch PA; Feldman BM; Perez MD; Zemel LS; Lindsley CB; Rennebohm RM; Wallace CA; Passo MH; Reed AM; Bowyer SL; Ballinger SH; Miller FW; Rider LG;
    Arthritis Rheum; 2008 Feb; 59(2):214-21. PubMed ID: 18240194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quality of life correlates with muscle strength in patients with dermato- or polymyositis.
    Poulsen KB; Alexanderson H; Dalgård C; Jacobsen S; Weile L; Diederichsen LP
    Clin Rheumatol; 2017 Oct; 36(10):2289-2295. PubMed ID: 28585061
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patients' Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure - Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12.
    Regardt M; Basharat P; Christopher-Stine L; Sarver C; Björn A; Lundberg IE; Wook Song Y; Bingham CO; Alexanderson H
    J Rheumatol; 2015 Dec; 42(12):2492-5. PubMed ID: 25934817
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Spontaneous electromyographic activity in polymyositis].
    Krstić S; Bozović D; Radojicić B; Ivković-Zdravković J
    Neurologija; 1979; 27(1-4):35-8. PubMed ID: 262017
    [No Abstract]   [Full Text] [Related]  

  • 74. A scale to assess activities of daily living in persons affected by leprosy.
    van Brakel WH; Anderson AM; Wörpel FC; Saiju R; Bk HB; Sherpa S; Sunwar SK; Gurung J; De Boer M; Scholten E
    Lepr Rev; 1999 Sep; 70(3):314-23. PubMed ID: 10603721
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interrater reliability and aspects of validity of the myositis damage index.
    Sultan SM; Allen E; Cooper RG; Agarwal S; Kiely P; Oddis CV; Vencovsky J; Lundberg IE; Dastmalchi M; Hanna MG; Isenberg DA
    Ann Rheum Dis; 2011 Jul; 70(7):1272-6. PubMed ID: 21622773
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Activities of daily living scale for patients with chronic pain.
    Linton SJ
    Percept Mot Skills; 1990 Dec; 71(3 Pt 1):722. PubMed ID: 2293174
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Electromyography in polymyositis and dermatomyositis.
    Fredericks EJ
    Muscle Nerve; 1994 Oct; 17(10):1235-6. PubMed ID: 7935541
    [No Abstract]   [Full Text] [Related]  

  • 78. The heart in polymyositis-dermatomyositis.
    Agrawal CS; Behari M; Shrivastava S; Ahuja GK; Bhandari S; Kothari SS
    J Neurol; 1989 May; 236(4):249-50. PubMed ID: 2760639
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Polymyositis syndrome].
    Kuroiwa Y
    Shinkei Kenkyu No Shimpo; 1965 Jul; 9(2):384-9. PubMed ID: 5893882
    [No Abstract]   [Full Text] [Related]  

  • 80. Polymyositis exacerbated by gemfibrozil.
    Fusella J; Strosberg JM
    J Rheumatol; 1990 Apr; 17(4):572-3. PubMed ID: 2348445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.